Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Sunitinib, Pancreatic NETs

Alain Ravaud

MD, PhD

🏢Bordeaux University Hospital🌐France

Professor of Medical Oncology

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Alain Ravaud is a French medical oncologist who participated in the registration trial for sunitinib in pancreatic NETs, helping establish it as a regulatory-approved therapy. His research spans VEGFR-targeted approaches and combination strategies for advanced NETs. He has contributed to European NET guideline development and the design of international multicenter NET trials. His work has bridged basic vascular biology research with clinical outcomes in endocrine tumors.

Share:

🧪Research Fields 研究领域

sunitinib pancreatic NET
angiogenesis NETs
VEGFR inhibition NETs
pancreatic neuroendocrine tumors
clinical trials NETs

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Alain Ravaud 的研究动态

Follow Alain Ravaud's research updates

留下邮箱,当我们发布与 Alain Ravaud(Bordeaux University Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment